Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
15.91
+1.08 (7.28%)
Feb 13, 2026, 9:42 AM EST - Market open
Eikon Therapeutics Market Cap
Eikon Therapeutics has a market cap or net worth of $858.89 million as of February 13, 2026.
Market Cap
858.89M
Enterprise Value
665.46M
1-Year Change
n/a
Ranking
Category
Stock Price
15.91
Market Cap Chart
Since the IPO on February 5, 2026, Eikon Therapeutics's market cap has decreased from $971.72M to $858.89M, a decrease of -11.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 800.59M | 2.35% |
| Feb 11, 2026 | 782.23M | 6.62% |
| Feb 10, 2026 | 733.65M | -6.60% |
| Feb 9, 2026 | 785.47M | 0.34% |
| Feb 6, 2026 | 782.77M | -19.44% |
| Feb 5, 2026 | 971.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xencor | 833.36M |
| Omeros | 811.10M |
| Janux Therapeutics | 789.74M |
| Bright Minds Biosciences | 775.75M |
| Annexon | 773.60M |
| Maravai LifeSciences Holdings | 772.23M |
| Arbutus Biopharma | 771.22M |
| Bicara Therapeutics | 770.23M |